Sunday, February 17, 2013 8:26:30 PM
We are a TAKEOVER Target...................
The most obvious suitor is ROCHE because they have HERCEPTIN
...and by acquiring SBFM they could DOMINATE the breast cancer treatment field. AZN may get into a BIDDING WAR with Roche..they have cash out the WAZOO and need to increase their PIPLINE
"When deals come up we want to be at the table," says Martin Mackay, who stepped in as R&D chief at AstraZeneca ($AZN) two years ago, in an interview with FierceBiotech. "We want to be players."
Read more: AstraZeneca's R&D chief vows to keep 'pedal to the metal' - FierceBiotech http://www.fiercebiotech.com/story/astrazenecas-rd-chief-vows-keep-pedal-metal/2012-07-03#ixzz204bTnlcU
The most obvious suitor is ROCHE because they have HERCEPTIN
...and by acquiring SBFM they could DOMINATE the breast cancer treatment field. AZN may get into a BIDDING WAR with Roche..they have cash out the WAZOO and need to increase their PIPLINE
"When deals come up we want to be at the table," says Martin Mackay, who stepped in as R&D chief at AstraZeneca ($AZN) two years ago, in an interview with FierceBiotech. "We want to be players."
Read more: AstraZeneca's R&D chief vows to keep 'pedal to the metal' - FierceBiotech http://www.fiercebiotech.com/story/astrazenecas-rd-chief-vows-keep-pedal-metal/2012-07-03#ixzz204bTnlcU
Recent SBFM News
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
